Drugs / Modified Qing-Ying Decoction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04419584 | Sep 2020 → Dec 2022 | atopic eczema | Chinese University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified Qing-Ying Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04419584 ↗ |
| Known as | mQYD | “The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children” NCT04419584 ↗ |
| Route | Oral | “They will receive oral herbal mQYD or placebo granules for 12 weeks” NCT04419584 ↗ |